Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy

Objective: Immune checkpoint inhibitors (ICIs) have recently demonstrated promising performance in improving the prognosis of urological cancer patients. The goal of this meta-analysis was to determine the impact of PPI use on the clinical outcomes of urological cancer patients receiving ICI therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lilong, Chen, Chen, Chai, Dongqi, Li, Chunlei, Kuang, Tianrui, Liu, Li, Dong, Keshuai, Deng, Wenhong, Wang, Weixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549125/
https://www.ncbi.nlm.nih.gov/pubmed/36225582
http://dx.doi.org/10.3389/fphar.2022.1018411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549125/
https://www.ncbi.nlm.nih.gov/pubmed/36225582
http://dx.doi.org/10.3389/fphar.2022.1018411

Ejemplares similares